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Background: Persistent formal thought disorder (FTD) is one of themost characteristic features of schizophrenia.
Several neuroimaging studies report spatially distinct neuroanatomical changes in association with FTD. Given
that most studies so far have employed a univariate localisation approach that obscures the study of covarying
interregional relationships, the present study focussed on themultivariate systemic pattern of anatomical chang-
es that contribute to FTD.
Methods: Speech samples from nineteen medicated clinically stable schizophrenia patients and 20 healthy con-
trols were evaluated for subtle formal thought disorder. Ultra high-ﬁeld (7 T) anatomical Magnetic Resonance
Imaging scans were obtained from all subjects. Multivariate morphometric patterns were identiﬁed using an in-
dependent component approach (source basedmorphometry). Using multiple regression analysis, the morpho-
metric patterns predicting positive and negative FTD scores were identiﬁed.
Results:Morphometric variations in grey matter predicted a substantial portion of inter-individual variance in
negative but not positive FTD. A pattern of concomitant striato-insular/precuneus reduction along with
frontocingular grey matter increase had a signiﬁcant association with negative FTD.
Conclusions: These results suggest that concomitant increase and decrease in grey matter occur in association
with persistent negative thought disorder in clinically stable individuals with schizophrenia.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Formal thought disorder (FTD) is one of the deﬁning features of
schizophrenia. FTD is closely related to the constructs of disorganisation
syndrome andhebephrenia andhas been reported in 80–90% of individ-
uals with acute psychosis in some samples (Andreasen, 1979; Harrow
et al., 1986; Harrow and Marengo, 1986). In particular, persistence of
FTD is considered as a core feature of the long-term course of schizo-
phrenia (Harvey et al., 1984). In a follow-up study persistent FTD was
observed in 64% of patients with schizophrenia, while only 33% patients
with non-schizophreniform psychosis displayed such persistence
7.5 years after the ﬁrst psychotic episode (Marengo and Harrow, 1997).
Structural basis of persistent thought disorder has been a matter of
interest for the last 20 years, but continues to be unclear. A largemajority
of studies have focused on the superior temporal gyrus (STG) as a region-
of-interest (ROI) while examining the structural basis of FTD. Severallth, Triumph Road, Nottingham
(L. Palaniyappan).
. This is an open access article under(Menon et al., 1995; Shenton et al., 1992; Subotnik et al., 2003;
Weinstein et al., 2007) but not all (Flaum et al., 1995; Kim et al., 2003;
Molina et al., 2003) of these studies have found an association between
reduced volume of STG and the severity of FTD. Morphometric
abnormalities in other ROIs such as the inferior frontal gyrus (Suga
et al., 2010), supramarginal gyrus (Palaniyappan and Liddle, 2012),
orbitofrontal cortex (Nakamura et al., 2008), cerebellum (Kühn et al.,
2012), amygdala (Rajarethinam et al., 2001) and parahippocampal
gyrus (Prasad et al., 2004) have also been related to disorganisation or
FTD. Whitford et al. (2005) and Lui et al. (2009) undertook whole brain
voxelwise studies comparing patients and controls, but restricted the
study of disorganisation to ROIs that showed signiﬁcant effect of diagno-
sis, thus precluding unbiased inference on the spatial distribution of
structural correlates of FTD. A small number of whole brain studies
have investigated the association between disorganisation/FTD andmor-
phometric changes across the entire brain without prior anatomical as-
sumptions. STG volume reductions were noted in some (Horn et al.,
2009, 2010; Leube, 2009; Sans-Sansa et al., 2013) but not all (Chua
et al., 1997; Rigucci et al., 2013) studies. Other regions showing FTD-
related morphometric changes in the whole brain studies include thethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Sans-Sansa et al., 2013), OFC (Horn et al., 2010; Sans-Sansa et al.,
2013), anterior cingulate cortex (Horn et al., 2009; Sans-Sansa et al.,
2013), hippocampal region (Chua et al., 1997), lingual gyrus (Horn
et al., 2010), occipital lobe (Horn et al., 2010; Rigucci et al., 2013),
precuneus (Horn et al., 2009), angular gyrus (Horn et al., 2009) and tem-
poral pole (Horn et al., 2010). In summary,morphometric studies to date
implicate distributed brain regions to be relevant to the pathophysiology
of FTD, though no consistent reports have emerged.
Inconsistent observations of structural changes in relation to FTD
could be attributed to various factors. Firstly, previous morphometric
studies have adopted a univariate approach in seeking the structural
basis of FTD. These studies assume that between subjects, regional varia-
tions in brain structure are spatially distinct, and do not take into account
the covariance or interrelationship that exists among distributed regions.
This issue is especially important in the investigation of schizophrenia,
where structural changes affecting distributed ‘systems’ in the brain,
rather than single regions, are suspected to underlie the complex clinical
symptoms observed in patients. Secondly, the prominence of FTD varies
with the clinical stage of the psychotic illness (Arndt et al., 1995; Russo
et al., 2013). It is possible that only a small portion of the variance in
such state-related symptom severity could be related to the structural
variations in the brain (Mathalon and Ford, 2012). In contrast, morpho-
metric changes might relate better to persistent, trait-like FTD seen in
clinically stable subjects despite adequate treatment. Moreover, subtle
aspects of FTD are often missed during the course of clinical interactions
(De Bruin et al., 2007); an adequate assessment of FTD requires unstruc-
tured, freely generated speech samples (Johnston et al., 1986; Liddle et al.,
2002a; Kircher et al., 2014). Finally, most structural MRI studies (except
Sans-Sansa et al., 2013) have sought the neural correlates for overall se-
verity of FTD as a single construct, though functional imaging studies in-
dicate that the pathophysiology of positive FTD characterized by
looseness andpeculiarword, sentence or logic usagemaydiffer fromneg-
ative FTD characterized by poverty of speech and weakening of goal
(Kircher et al., 2001, 2003; McGuire et al., 1998a,b).
A multivariate statistical approach called source-based morphometry
(SBM) offers a novel means to study the patterns of morphometric varia-
tions in grey matter in relation to disease states (Xu et al., 2009). In this
approach, the term ‘source’ refers to independent spatial components de-
rivedwithout any a-priori assumptions that have similar patterns ofmor-
phometric variability between subjects. Due to its multivariate nature,
SBM reveals linked sub-systems or ‘macrocircuits’ in the brain that relate
to a clinical phenotype (Caprihan et al., 2011). Several recent studies have
utilized this approach to investigate clinical features (Kubera et al., 2013;
Wolf et al., 2014) in psychotic disorders. In the present study,we aimed to
identify spatially independent, SBM-derived greymatter components at a
whole brain level that predict positive andnegative FTD in clinically stable
subjects with schizophrenia. To this end, we quantiﬁed FTD using freely
generated speech sample. Further, we collected structural scans from an
ultra high ﬁeld 7-Tesla MRI scanner. 7 T MRI offers higher signal-to-
noise resolution compared to lower ﬁeld scans (Metcalf et al., 2010),
and offers superior accuracy in discriminating structural changes seen in
patients with schizophrenia (Iwabuchi et al., 2013). Given the inconsis-
tency of previous structural studies, we made no a priori assumptions as
to the brain regions implicated in FTD, but hypothesized the presence of
structural alterations across distributed anatomical ‘subsystems’ in rela-
tion to the variations in severity of persistent FTD in clinically stable pa-
tients with schizophrenia.
2. Methods
2.1. Participants
The characteristics of the sample used in this study have been de-
scribed previously (Iwabuchi et al., 2013). 20 patients and 21 healthy
controls aged between 18–55 years were recruited, of which 19 patientsand 20 controls had scans of adequate quality for morphometric analy-
ses. Patients satisﬁed the diagnostic criteria for schizophrenia according
to DSM-IV criteria assessed on the basis of a consensus procedure
based on a reviewof caseﬁles, information from thepsychiatrists provid-
ing direct clinical care and a structured clinical interview (Signs and
Symptoms of Psychotic Illness, (Liddle et al., 2002b)) to assess clinical
features. Patients were speciﬁcally recruited in a stable phase of illness
(deﬁned as a change of no more than 10 points in their Global Assess-
ment of Function (GAF, DSM-IV) score, assessed six weeks prior and im-
mediately prior to study participation). Patient recruitment was carried
out in Nottinghamshire, from cases registered with generic community
mental health teams, ﬁrst episode teams or rehabilitation teams. The
mean duration of illness was 7.7 years (SD= 8.3). Subjects with neuro-
logical disorders, current substance dependence, or IQ b 70 using Quick
Test (Ammons and Ammons, 1962) were excluded. Healthy controls
group-matched for age, gender and parental socioeconomic status
were recruited from the local communities. Controls had no personal
or family history of psychosis and were free of neuropsychiatric disor-
ders as assessed by a research psychiatrist. The study was conducted in
Nottinghamshire, UKwith ethical permission obtained from theNational
Research Ethics Committee, Nottingham. All participants gave written
informed consent and received monetary compensation for their time
in accordance with the ethical approval.
2.2. MRI data acquisition
Scanning was performed on a 7 T Philips Achieva system with 32-
channel receive coil. T1 weighted images were acquired using a 3D
Magnetization Prepared-Turbo Field Echo (IR-TFE) with 0.6 mm isotro-
pic resolution, 192 × 180 × 140 mmmatrix, TR = 15 ms, TE = 5.6 ms,
shot interval= 3 s, and ﬂip angle 8°. An optimized inversion pulse (adi-
abatic pulse) was used at 7 T to reduce bias ﬁeld inhomogeneity. One
patient and one control were excluded due to signiﬁcant movement
artefacts. T1 weighted images were resliced (1 mm isotropic) and seg-
mented into grey, white and CSF tissue using the SPM8 Diffeomorphic
Anatomical Registration Through Exponentiated Lie algebra (DARTEL) al-
gorithm (Ashburner, 2007) using a study-speciﬁc template. To correct for
variation due toﬁeld inhomogeneity, the imageswere biasﬁeld corrected
using 60 mm FWHM setting using SPM8 (Uwano et al., 2013). Further
precautions taken to reduce bias ﬁeld inhomogeneity are described in
our previouswork (Iwabuchi et al., 2013).Modulated greymatter images
were normalized to MNI space using DARTEL's high-dimensional
normalization protocol and smoothed using a 8 mm isotropic Gaussian
kernel in line with recent SBM studies (Kubera et al., 2013; Wolf et al.,
2014). Intracranial volume was calculated as a sum of the partial
volumes derived from greymatter, white matter and CSF tissue images.
2.3. Assessment of thought disorder
Subjects were interviewed on the same day as the scan to assess
seven features of formal thought disorder (poverty of speech, weaken-
ing of goal, perseveration, looseness, peculiar word usage, peculiar sen-
tence usage and peculiar logic) in line with the validated procedure for
administering Thought Language Index (Liddle et al., 2002a). To gener-
ate free speech samples, 3 pictures from Thematic Apperception Test
(Murray, 1943) were used as in the study by Sommer et al. (2010).
Speech samples were audio recorded by two research psychiatrists
(LP and VB) and transcribed and rated by a single author (JM) blind to
the diagnostic status, symptom burden of the subjects and neuroimag-
ing ﬁndings. During the training phase, several meetings were orga-
nized among the authors to develop consensus on how to interpret
and score FTD using previously collected speech samples. Further, we
used the examples from the original author (PFL) for reference. In keep-
ing with the original description of the scale, the summed scores of
looseness, peculiarword, peculiar sentence and peculiar logicwere clas-
siﬁed as positive FTD (disorganised thinking) and the summed scores of
Table 1
Clinical and demographic features.
Features Patients (N = 19)
Mean(SD)
Controls (N = 20)
Mean(SD)
Statistic
Gender (male/female) 14/5 15/5 χ2 = 0.93
Handedness (right/left) 17/2 18/2 χ2 = 0.45
Age 33.2(9.8) 32(8.2) t = 0.44
Parental NS-SEC 2.6(1.7) 2.5(1.6) z = 0.16
SSPI total score 11.1(10) 0.6(0.8) z = 5.0⁎
Reality distortion 2.4(2.9) 0(0) z = 3.9⁎
Disorganisation 0.2(0.7) 0.1(0.3) z = 3.0⁎
Psychomotor poverty 2.3(3.7) 0(0) z = 2.9⁎
Illness duration (years) 7.7(8.3) –
DDD of antipsychotics 0.8(0.7) –
GAF score 47.3(10.7) 88.1(7.4) t =−13.9⁎
Impoverished thinking
(negative FTD)
0.486(0.89) 0.042(0.10) z = 2.16⁎a
Disorganised thinking
(positive FTD)
0.556(0.67) 0(0) z = 4.31⁎a
Intracranial volume (ml) 1558.6(169.1) 1593.3(146.8) t =−0.68
SD: Standard deviation. NS-SEC: National Statistics Socio-economic Classiﬁcation. SSPI:
Signs and Symptoms of Psychotic Illness. DDD: Deﬁned Daily Dose. GAF: Global Assess-
ment of Functioning.
a 2 patients and 1 control excluded for missing values due to poor quality of audio
transcripts.
⁎ Signiﬁcantly different between the two groups at p b 0.05.
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negative FTD (impoverished thought). The inclusion of perseveration
with negative FTD has been supported by some (Andreasen and
Grove, 1986) but not all factor analyses (Liddle et al., 2002a).We repeat-
ed our primary analysis (reported below) after excluding perseveration
scores from negative FTD. This did not affect the overall results
(Supplementary material).
3. Source based morphometry
SBM analysis was carried out using Group ICA Toolbox as per the
standard descriptions provided by the authors (Xu et al., 2009). For
this procedure, each grey matter image was converted to a one-
dimensional vector of voxel-speciﬁc values and arrayed into a 39-row
subjects-by-voxels matrix. The number of independent components
was estimated using minimum description length criteria (Li et al.,
2007). The subjects-by-voxels matrix was decomposed into a mixing
matrix (subjects-by-components) representing loading parameters
that quantify the contribution of each subject to the group for a given
component and source matrix (components-by-voxels) representing
the spatially independent ‘sub-systems’ deﬁned on the basis ofmorpho-
metric covariancewithin the group (see the Supplementarymaterial for
further details).We employed a bootstrapping algorithm(20 iterations)
to increase the stability of the estimated components (Himberg et al.,
2004). Further second-level statistical analysis was carried out on the
loading parameters. To visualize the spatial components, the sourcema-
trix was recomposed to statistical maps in 3 dimensional MNI space
with coefﬁcients expressed in standard deviation units (z-maps). The
anatomical descriptions of these maps were obtained using Talairach
coordinates utility in the GIFT toolbox.
The greymatter intensity in each voxel in each subject (after remov-
al of the groupmean) is the sum of 8 product values obtained frommul-
tiplying the voxel loading for each component with its coefﬁcient for
that subject. As a result, the sign of the loading coefﬁcients of a compo-
nent in a subject do not directly provide the direction of change in abso-
lute grey matter intensity in a region (Caprihan et al., 2011). To address
this sign ambiguity and to directly interpret the direction of morpho-
metric changes within the spatial components, we derived the mean
grey matter volume from all voxels with z N 2 within a component for
each subject, and adjusted the signs of the ICAmaps so that the correla-
tion of loading coefﬁcients with grey matter volume is positive within
each map. This procedure, in line with Caprihan et al. (2011), allowed
us to interpret whether an overall increase or decrease in component-
speciﬁc grey matter accounted for a higher burden of FTD in an individ-
ual (Supplementary material).
4. Statistical analysis
All statistical testswere carried out using SPSS version 21.0 (IBMCorp.,
Armonk, NY). Clinical and demographic variables were compared be-
tween patients and controls using t tests (or Mann–Whitney U tests for
non-normal data) and chi-square tests for proportions. A patient vs.
controls comparison on the 8 spatial components was performed using
multivariate analysis of variance (MANOVA) followed by Bonferroni
corrected univariate ANOVAs for each component. Age, gender and intra-
cranial volumewere used as covariates for this analysis as these variables
could affect the regional grey matter distributions. In the patient group,
multiple regression analyses were conducted separately to predict posi-
tive and negative FTD using all of the 8 ICA parameters, entered simulta-
neously into the regressionmodels after excludingmulticollinearity using
a tolerance threshold of 0.1. The relationship between current antipsy-
chotic dose and the grey matter components was studied by relating
the loading parameters with Deﬁned Daily Dose equivalents of antipsy-
chotics (WHO Collaborating Centre for Drug Statistics and Methodology,
2003) using Spearman's correlation.We did not have data on cumulative
antipsychotic exposure for this sample.5. Results
Clinical and demographic features of the sample are presented in
Table 1. The two groupswerewellmatched for age, gender and parental
socioeconomic status. Positive FTD was seen only in patients, but nega-
tive FTDwas noted in both patients and controls, with higher degree of
severity in patients.
Theminimumdescription length criteria revealed 8 independent spa-
tial components with covarying greymatter patterns in the SBM analysis.
The anatomical description of the regions included in each component is
presented in Table 2.MANOVA revealed a signiﬁcant group difference be-
tween patients and controls in the loading coefﬁcients [F(8, 27) = 2.72,
p = 0.024]. The effect of diagnosis was most pronounced for IC2 [F(1,
34) = 11.9, p= 0.008; coefﬁcient mean(SD) in controls = 0.44(0.18),
patients =−0.46(0.19)] and IC6 [F(1, 34) = 9.7, p= 0.03; coefﬁcient
mean(SD) in controls = 0.23(0.11), patients =−0.24(0.11)]. No other
signiﬁcant between-group differences were noted. IC2 included the
precuneus, posterior cingulate, superior temporal, lingual and fusiform
gyrus, middle occipital, precentral and paracentral regions and middle
frontal gyrus. IC6 included the superior, middle and inferior temporal
gyrus, precuneus and posterior cingulate regions, medial and inferior
frontal regions. The spatial distribution of these two components is
presented in Fig. 1. In both IC2 and IC6, controls had a higher volume of
grey matter than patients.
The regression models were signiﬁcant for negative FTD (F = 2.65,
p=0.026) with the loading coefﬁcients of IC4, IC5 and IC7 (Fig. 2) signif-
icantly predicting negative FTD in patients. These three variables ex-
plained most of the variance (adjusted R2 = 67%) in the negative FTD
scores.Higher coefﬁcient values in IC4 (dorsal anterior cingulate, superior,
middle andmedial frontal regions) and IC7 (superior, inferior,middle and
medial frontal), and lower values in IC5 (striatum, insula, superior tempo-
ral, posterior cingulate andprecuneus)were associatedwithnegative FTD
(Table 3). The multiple regression models were not signiﬁcant for
predicting positive FTD in patients (F = 2.65, p= 0.026) or the clinical
syndrome scores (reality distortion, psychomotor poverty and
disorganisation) obtained from the SSPI interview (further details in the
Supplementary material). In controls, the morphometric variations in
the 8 spatial components did not predict the negative FTD (F = 1.22,
p= 0.38). Daily doses of antipsychotics (current exposure) were not re-
lated to the greymatter variations in any of the SBMderived components
(all p N 0.4) (Supplementary Material).
Table 2
Anatomical description of the independent components.
Anatomical regions Max z value (Talairach coordinates x,y,z)
for left/right hemispheres.
Component IC1
Precuneus 4.1 (−39,−65, 35)/8.8 (25,−62, 35)
Superior temporal gyrus 4.5 (−46,−57, 28)/6.6 (46,−50, 15)
Middle temporal gyrus na/6.3 (50,−43, 5)
Supramarginal gyrus 6.2 (−55,−39, 36)/4.9 (55,−46, 35)
Postcentral gyrus 5.0 (−56,−14, 33)/6.1 (52,−20, 34)
Inferior parietal lobule 4.7 (−59,−40, 24)/5.6 (59,−29, 32)
Middle frontal gyrus 4.9 (−36, 26, 32)/na
Angular gyrus na/4.9 (43,−61, 33)
Precentral gyrus 4.6 (−46,−20, 37)/4.1 (56,−1, 15)
Inferior frontal gyrus 3.6 (−40, 42, 2)/na
Component IC2
Precuneus 7.7 (−16,−60, 31)/8.1 (15,−60, 20)
Posterior cingulate 7.2 (−21,−56, 8)/7.4 (18,−56, 7)
Cuneus 4.7 (−9,−78, 8)/6.7 (12,−66, 30)
Superior temporal gyrus na/5.6 (45,−52, 15)
Lingual gyrus 5.2 (−15,−48, 2)/5.0 (6,−83, 4)
Precentral gyrus 4.1 (−33,−19, 49)/4.6 (28,−22, 52)
Middle occipital gyrus 4.3 (−37,−77, 11)/3.8 (36,−77, 12)
Middle frontal gyrus 3.5 (−33,−1, 46)/4.1 (36, 11, 26)
Paracentral lobule na/4.0 (9,−38, 54)
Fusiform gyrus na/3.9 (45,−43,−14)
Cingulate gyrus 3.7 (−10,−20, 40)/3.7 (9,−21, 40)
Component IC3
Inferior semi-lunar lobule 6.7 (−28,−71,−42)/5.9 (15,−69,−41)
Nodule 4.9 (−3,−52,−30)/na
Declive 4.5 (−34,−59,−22)/4.3 (30,−62,−21)
Uvula 4.3 (−9,−69,−32)/4.0 (7,−66,−33)
Cerebellar tonsil 3.9 (−40,−50,−42)/na
Lingual gyrus na/3.9 (13,−72,−4)
Culmen 3.7 (−36,−48,−25)/3.8 (36,−52,−24)
Pyramis 3.8 (−25,−74,−27)/na
Component IC4
Middle frontal gyrus 6.7 (−27,−8, 53)/7.4 (15,−7, 61)
Superior frontal gyrus 3.8 (−27,−8, 64)/5.2 (12, 19, 54)
Inferior parietal lobule 5.2 (−39,−46, 40)/na
Inferior frontal gyrus 4.0 (−48, 6, 29)/4.3 (46, 4, 30)
Anterior cingulate 4.0 (−7, 30, 23)/4.1 (6, 29, 23)
Cingulate gyrus 3.7 (−7, 22, 35)/na
Medial frontal gyrus 3.7 (−7,−10, 60)/na
Component IC5
Lentiform nucleus 7.5 (−19, 11,−6)/7.0 (18, 11,−6)
Cingulate gyrus 6.3 (−7,−42, 35)/4.8 (4,−37, 39)
Parahippocampal gyrus na/5.2 (22,−10,−17)
Caudate 4.8 (−12, 18, 1)/3.7 (10, 15, 2)
Middle temporal gyrus 3.6 (−43,−61, 10)/4.5 (42,−64, 11)
Precuneus 4.4 (−4,−50, 43)/4.2 (7,−46, 33)
Superior frontal gyrus 4.4 (−15, 16, 57)/4.0 (16, 48, 28)
Precentral gyrus na/4.3 (37, 13, 34)
Superior temporal gyrus 4.2 (−43,−51, 25)/na
Middle occipital gyrus 4.1 (−40,−76, 1)/na
Paracentral lobule na/4.0 (4,−37, 50)
Posterior cingulate 3.8 (−1,−60, 22)/na
Insula na/3.8 (33, 18, 6)
Inferior temporal gyrus 3.7 (−56,−17,−16)/na
Postcentral gyrus 3.7 (−7,−48, 65)/na
Inferior occipital gyrus na/3.5 (43,−75,−5)
Component IC6
Middle temporal gyrus 5.6 (−52,−7,−14)/5.9 (52,−11,−12)
Fusiform gyrus 3.7 (−61,−13,−23)/5.4 (50,−3,−23)
Posterior cingulate na/4.3 (15,−61, 10)
Superior temporal gyrus 3.6 (−58,−29, 3)/4.2 (49, 11,−17)
Inferior frontal gyrus na/4.1 (40, 2, 33)
Inferior temporal gyrus 3.8 (−49,−2,−33)/4.1 (48,−5,−33)
Precuneus 3.9 (−16,−58, 29)/na
Medial frontal gyrus na/3.7 (10, 15,−17)
Middle occipital gyrus na/3.5 (42,−67, 9)
Component IC7
Superior frontal gyrus 6.8 (−16, 64,−7)/7.6 (24, 56,−8)
Inferior frontal gyrus 3.8 (−43, 38, 4)/7.6 (37, 42, 1)
Table 2 (continued)
Anatomical regions Max z value (Talairach coordinates x,y,z)
for left/right hemispheres.
Component IC7
Middle frontal gyrus 7.0 (−27, 56,−7)/4.9 (36, 52,−5)
Medial frontal gyrus 6.1 (−10, 64, 2)/5.2 (7, 61, 0)
Precuneus na/5.4 (25,−65, 35)
Superior parietal lobule 5.3 (−28,−55, 43)/na
Inferior parietal lobule na/5.0 (49,−40, 24)
Postcentral gyrus na/4.3 (43,−26, 37)
Anterior cingulate 4.0 (−9, 47,−1)/na
Middle temporal gyrus 3.8 (−49,−36, 5)/na
Component IC8
Middle occipital gyrus 8.2 (−37,−80, 12)/7.2 (24,−91, 9)
Cuneus 6.7 (−12,−89, 18)/6.3 (7,−91, 14)
Middle temporal gyrus 4.5 (−45,−72, 17)/4.6 (43,−72, 19)
Precuneus 4.2 (−18,−72, 40)/na
Inferior occipital gyrus 4.1 (−27,−91,−4)/4.1 (36,−82,−5)
Superior occipital gyrus na/3.5 (36,−77, 27)
The anatomical regions within each component are summarized after thresholding the z-
maps at z N 3.5. To avoid reduplication, only regions with positive contribution to the co-
variance are listed. na: no effect with z N 3.5.
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To our knowledge, this is the ﬁrst study employing a multivariate
morphometric procedure to study thought disorder in schizophrenia.
In this study, we have shown that (1) clinically stable andmedicated in-
dividuals with schizophrenia exhibit FTD that is quantiﬁable by analyz-
ing speech samples, (2) a signiﬁcant proportion of the variance in
negative FTD is explained by morphometric variations in distributed
brain regions (especially frontotemporal cortex, striatum, insula, anteri-
or and posterior cingulate cortex and precuneus) and (3) both increased
and decreased grey matter volumes are noted in association with FTD.
With respect to the regression analysis, we noted that a reduction in
grey matter volume involving the striatum, insula, precuneus and later-
al temporal regions predicted higher burden of negative FTD, in the
presence of an increase in grey matter volume involving the cingulate
and lateral prefrontal regions. It is important to note that our results
point to a pattern of concomitant changes (both increases and decreases
in GMV), rather than speciﬁc regional changes, that best explain the var-
iance in negative FTD seen among clinically stable patients with schizo-
phrenia. While not directly comparable, these observations are partly
consistent with previous whole brain structural and functional studies
implicating the insula (Leube, 2009; Liddle et al., 1992), striatum
(Ebmeier et al., 1993; Liddle et al., 1992) precuneus (Horn et al., 2009)
and temporal cortex (Horn et al., 2009, 2010), though these studies
did not distinguish positive and negative FTD. To our knowledge only
one previous study (Sans-Sansa et al., 2013) has examined the structur-
al correlates of negative FTD. This study used Andreasen's Thought, Lan-
guage and Communication scale (Andreasen and Grove, 1986) and
employed voxelwise mass univariate approach. In Sans-Sansa et al.'s
study, poverty of content of speech was related to grey matter reduc-
tions in the orbitofrontal and insular cortex, while poverty of speech
was not quantiﬁed. In addition, positive FTD was associated with re-
duced grey matter volume in the superior temporal cortex and inferior
frontal cortex. These results are partly consistent with reduced insular
volume predicting severe negative FTD in our sample. Nevertheless,
we did not observe any structural basis for the positive FTD. While we
recruited clinically stable patients (not enriched for the presence of
thought disorder) to study otherwise subtle FTD, Sans-Sansa et al.
recruited hospitalized patients with chronic illness selected for the
presence of pronounced FTD (enriched sample). It is likely that such
pronounced positive FTD in chronic patients is associated with greater
structural abnormality than the subtler positive thought disorders in
the outpatient sample in the current study. Further, the variance of pos-
itive FTD (σ2 = 0.4) was limited compared to that of negative FTD
Fig. 1. Independent spatial componentswith reduced greymatter in patients compared to controls. IC2 is displayed in yellow-red; IC6 is displayed in blue-green. Slices selected for the best
display of the 2 components, overlaid on a template structural image using MRIcron software. The components are thresholded at z N 2.
309L. Palaniyappan et al. / Schizophrenia Research 168 (2015) 305–312(σ2 = 0.8) in our patient sample, thus restricting our ability to detect a
relationship with brain structure.
Our observations suggest that increased grey matter volume in the
prefrontal regions and dorsal anterior cingulate predicted more severe
negative FTD in patients, in the presence of concomitant GM reduction
in the bilateral insula, precuneus and striatum. Insofar as SBM revealsthe ‘macrocircuit’ patterns in greymatter structure, this observation sug-
gests that a structural imbalance between the insula/striatalmacrocircuit
on one hand and the frontocingular systemon the other could contribute
to negative FTD. Given the predominance of volumetric reduction in
schizophrenia, the observation of a structural pattern involving an in-
crease in GMV in certain regions in relation to thought disorder appears
Fig. 2. Independent spatial components (ICs) related to negative FTD in patients. Loading coefﬁcients of IC4 and IC7 increased while IC5 decreased with higher severity of negative FTD.
Binarymasks of the components thresholded at z N 2, overlaid on single subject anatomical image providedwith xjView software (www.alivelearn.net/xjview8). See Table 2 for anatom-
ical description of the ICs.
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relation to thought disorder (albeit positive FTD) has been previously
demonstrated in schizophrenia (Chua et al., 1997). An increase in
frontocingular volume could also be a secondary, probably an inefﬁcient
and inadequate compensatory response to the presence of thought dis-
order. Alternatively, patients with persistent FTD might have had a
higher lifetime exposure of antipsychotic treatment that could have con-
founded the volumetric changes (Stip et al., 2009). But at present, longi-
tudinal observational evidence in this regard suggests that antipsychotic
prescription is associated with reduced, rather than increased frontal
volume (Ho et al., 2011) (also see the Supplementary material). The
presence of increased prefrontal grey matter in patients with persistent
thought disorder is a novel observation arising from ourmultivariate ap-
proach; this suggests that the structural correlates of FTD involve both
increases and decreases in grey matter volume.Table 3
Multiple regression analysis.
Independent variables Dependent variables
Negative FTD
F = 4.86(0.015)
β(p value)
Positive FTD
F = 0.50(0.82)
β(p value)
IC1 −0.18(0.39) −0.29(0.48)
IC2 −0.14(0.66) −0.37(0.56)
IC3 0.13(0.73) −0.38(0.60)
IC4 0.95(0.006) 0.17(0.75)
IC5 −1.16(0.03) −0.04(0.97)
IC6 0.20(0.61) −0.01(0.99)
IC7 0.85(0.007) −0.09(0.84)
IC8 −0.15(0.56) −0.36(0.47)
Note: Values in bold letters are statistically signiﬁcant. IC: Independent component. FTD:
Formal thought disorder. SSPI: Signs and Symptoms of Psychotic Illness.With respect to the group contrast, we noted a signiﬁcant reduction
in the greymatter volume affecting the bilateral temporal lobe, fusiform
and lingual gyrus, precuneus/posterior cingulate cortex and several dis-
tributed regions in the frontal cortex and the insula. These ﬁndings rep-
licate the two previous multivariate morphometric observations that
employed SBM to study grey matter changes in schizophrenia. Xu
et al. (2009) reported a signiﬁcant bilateral temporal greymatter reduc-
tion along with and distributed reductions in the lateral frontal, insular,
lingual gyrus, and precuneus regions. Kaspárek et al. (2010) studied a
ﬁrst episode sample and reported bilateral temporal and reductions
along with distributed changes in other regions. The presence of grey
matter reduction affecting the lateral temporal macrocircuit appears
to be a consistent feature across studies in schizophrenia.
Our study has several strengths including the use of ultra high-ﬁeld
imaging, employing an objective measure of FTD using freely generated
speech samples, and the use of multivariate morphometric technique
to study a brain–symptom relationship. Several limitations must also
be borne in mind while interpreting the results of this study. The size
of our sample was limited, though comparable to several previous
whole brain studies of FTD (Horn et al., 2009, 2010).We recruited amed-
icated, clinically stable sample;while thismight have contributed to a re-
duction in the variance of symptom scores, this offered an opportunity to
study the persistent, stable, trait-like aspect of negative FTD. Further the
confounding effects of antipsychotics cannot be ruled out. Though we
studied the relationship between currently prescribed dose and the
brain structure, we lacked longitudinal data on antipsychotic exposure.
In summary, using a multivariate morphometric analysis, we have
demonstrated both increases and decreases in grey matter in association
with persistent negative thought disorder in clinically stable individuals
with schizophrenia. Our results suggest that several sub-systems
(or macrocircuits) are likely to be involved in the pathophysiology of
FTD; further longitudinal studieswithmultiple assessments of FTD are re-
quired to clarify whether some of these represent a compensatory rather
than primary change.
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